$BPTH +126%

$BPTH is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease.

They release today the news of a US patent for their technology.
Here is the link of the news.

I saved the graph of the day here.


Here is the 30 day graph.

You May Also Like

$MORF + 134% today.

$PAND +133% today an acquisition news

$GME +103% again on the day!

$GTEC +95%

Leave a Reply

Your email address will not be published. Required fields are marked *